Page 42 - 82_01
P. 42

Coronary ischemia-reperfusion: role of nitric oxide and endothelin-1. A Review

     and Vascular Function. Prog. Cardiovasc. Dis2015;57          dysfunction: EDRFs. Pflugers Arch 2010;459:1005–
     (5):423-30.                                                  13.

19. Triggle CR, Samuel SM, Ravishankar S, Marei I,           35. Linder L, Kiowski W, Buhler FR, Luscher TF. Indirect
     Arunachalam G, Ding H. The endothelium:                      evidence for release of endothelium-derived relaxing
     influencing vascular smooth muscle in many ways.             factor in human forearm circulation in vivo: blunted
     Can J Physiol Pharmacol2012;90 (6):713-38.                   response in essential hypertension. Circulation1990;
                                                                  81:1762–67.
20. Deanfield JE. Endothelial Function and Dysfunction.
     Testing and Clinical Relevance. Circulation2007;115:    36. Pacher P, Beckman JS, Liaudet L. Nitric Oxide and
     1285-95.                                                     Peroxynitrite in Health and Disease. Physiol Rev2007;
                                                                  87 (1):315–424.
21. Vanhoutte PM. History of Discovery, How We
     Learned to Say NO, Arteriosclerosis, Thrombosis, and    37. Nathan C, Xie QW. Regulation of biosynthesis of
     Vascular Biology 2009; 29: 1156-60.                          nitric oxide. J Biol Chem 1994;269:13725–28.

22. Furchgott RF, Zawadzki JV., The obligatory role of       38. Ignarro LJ. Nitric oxide: a unique endogenous
     endothelial cells in the relaxation of arterial smooth       signaling molecule in vascular biology. Biosci Rep
     muscle by acetylcholine, Nature 1980;27::373-76.             1999;19:51–71.

23. Hickey KA, Rubany G, Paul RJ, Highsmutg RF.              39. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide:
     Characterization of a coonary vasoconstrictor                physiology, pathophysiology, pharmacology.
     orioduced by endothelial cells. Am J. Physiol (Cell          Pharmacol Rev 1991;43:109–42.
     Physiolo) 1985;248 (5): C550-C556.
                                                             40. Furchgott RF, Martin W, Jothianandan D, Villani GM.
24. Furchgott RF. Endothelium-Derived Relaxing Factor:            Comparison of endothelium-dependent relaxation by
     Discovery, Early Studies, and Identification as Nitric       acetylcholine and endothelium-independent relaxation
     Oxide. Biosci Rep 1999;19 (4):235-51.                        by light in the rabbit aorta. In: Paton WD, Mitchell J,
                                                                  Turner P, editors. Proceedings of the IUPHAR 9th
25. Galley HF, Webster NR. Physiology of the                      International Congress of Pharmacology. London:
     endothelium. Br. J. Anaesth. 2004; 93 (1): 105–13.           Macmillan Press; 1984. pp. 149–57.

26. Brandes RP, Fleming I, Busse R. Endothelial aging.       41. Furchgott RF. Studies on relaxation of rabbit aorta by
     Cardiovasc. Res2005;66 (2): 286–94.                          sodium nitrite. The basis for the proposal that the acid
                                                                  activatable inhibitory factor from bovine retractor
27. Vanhoutte PM. Regeneration of the endothelium in              penis is inorganic nitrite and the endothelium-derived
     vascular injury. Cardiovasc. Drugs Ther2010;24 (4):          relaxing factor is nitric oxide. In: Vanhoutte PM,
     299–303.                                                     editor. Vasodilatation: Vascular Smooth Muscle,
                                                                  Peptides, and Endothelium. New York: Raven Press;
28. Voghel G, Carrier M, Fortier A, Thorin E, Perrault LP,        1988. pp. 401–14.
     Voghel G, Thorin-Trescases N, Farhat N, Nguyen A,
     Villeneuve L, Mamarbachi AM. Cellular senescence        42. Ignarro LJ, Harbison RG, Wood KS, Kadowitz PJ.
     in endothelial cells from atherosclerotic patients is        Activation of purified soluble guanylate cyclase by
     accelerated by oxidative stress associated with              endothelium-derived relaxing factor from
     cardiovascular risk factors. Mech. Ageing                    intrapulmonary artery and vein: stimulation by
     Dev2007;128 (11–12): 662–71.                                 acetylcholine, bradykinin and arachidonic acid. J
                                                                  Pharmacol Exp Ther 1986;237:893–900.
29. Thorin E, Thorin-Trescases N. Vascular endothelial
     ageing, heartbeat after heartbeat. Cardiovasc.          43. Ignarro LJ. Heme-dependent activation of soluble
     Res2009;84 (1): 24–32.                                       guanylate cyclase by nitric oxide: regulation of
                                                                  enzyme activity by porphyrins and metalloporphyrins.
30. Verma S, Buchannan MR, Anderson TJ. Endothelial               Semin Hematol 1989;26:63–76.
     function testing as a biomarker of vascular disease.
     Circulation2003;108:2054-59.                            44. Moncada S, Herman AG, Vanhoutte PM.
                                                                  Endothelium-derived relaxing factor is identified as
31. Anderson TJ, Phillips SA. Assessment and Prognosis            nitric oxide. Trends Pharmacol Sci 1987; 8:365–68.
     of Peripheral Artery Measures of Vascular Function.
     Prog Cardiovasc Dis 2015;57 (5), 497–509                45. Bredt DS, Hwang PM, Snyder SH. Localization of
                                                                  nitric oxide synthase indicating a neural role for nitric
32. Dancu M B, Tarbell JM. Coronary endothelium                   oxide. Nature 1990; 347:768–70.
     expresses a pathologic gene pattern compared to aortic
     endothelium: correlation of asynchronous                46. Bredt DS, Snyder SH. Nitric oxide mediates
     hemodynamics and pathology in vivo.                          glutamate-linked enhancement of cGMP levels in the
     Atherosclerosis2007;192 (1):9-14.                            cerebellum. Proc Natl Acad Sci USA. 1989;86:9030–
                                                                  33.
33. Ludmer PL, Selwyn AP, Shook TL, Wayne RR,
     Mudge GH, Alexander RW, Ganz P. Paradoxical             47. Grasemann H, Drazen JM, Deykin A, Israel E, De
     vasoconstriction induced by acetylcholine in                 Sanctis GT, Pillari A, Yandava CN. Simple tandem
     atherosclerotic coronary arteries. N Engl J Med1986;         repeat polymorphisms in the neuronal nitric oxide
     315 (17):1046-51.                                            synthase gene in different ethnic populations. Hum

34. Flammer AJ, Luscher TF. Human endothelial

@Real Academia Nacional de Farmacia. Spain                                      41
   37   38   39   40   41   42   43   44   45   46   47